Summary

The global surgical devices market is projected to reach USD 296.76 billion by 2031, growing from USD 188.74 billion in 2026, at a CAGR of 9.5% during the forecast period. The growth of the surgical devices market is primarily driven by the rising prevalence of chronic diseases, increasing aging populations, and growing adoption of minimally invasive and robotic-assisted surgeries, which are increasing global surgical procedure volumes. Significant opportunities exist in the expansion of surgical robotics and rapidly growing ambulatory surgery centers, particularly in emerging markets. However, market growth is challenged by the high capital costs associated with advanced surgical technologies, long equipment replacement cycles, and shortages of skilled surgeons and technical personnel required to effectively operate sophisticated surgical systems and equipment. “By product, the capital equipment segment is expected to grow at the highest CAGR in the surgical devices market during the forecast period.” By product, the surgical devices market includes implants, capital equipment, single-use consumables, surgical endoscopy equipment, reusable surgical instruments, and accessories & ancillary products. Among these, the capital equipment segment is expected to grow the fastest during the forecast period. This growth is driven by increasing adoption of surgical robotic systems, advanced imaging and navigation platforms, surgical visualization systems, operating room integration devices, and energy-based surgical technologies. Healthcare providers are investing in these technologies to improve surgical precision, procedural efficiency, patient outcomes, and minimally invasive surgery capabilities. The growing volume of complex surgical procedures, rising demand for robotic-assisted surgery, and expansion of digital operating rooms are further accelerating capital equipment adoption. Additionally, continuous technological advancements incorporating artificial intelligence, real-time imaging, and data analytics are encouraging hospitals to modernize surgical infrastructure, supporting the rapid growth of the capital equipment segment. “By end user, the ambulatory surgery centers segment is expected to grow at the highest CAGR in the surgical devices market during the forecast period.” End users categorize the surgical devices market into hospitals, specialty clinics, ambulatory surgery centers, and other end users. Among these, the ambulatory surgery center segment is expected to grow at the highest CAGR in the surgical devices market during the forecast period. This is primarily due to the increasing shift of surgical procedures from hospitals to lower-cost outpatient settings. Advancements in minimally invasive surgery, robotic-assisted procedures, anesthesia techniques, and postoperative care have enabled a growing number of surgeries to be performed safely in ASCs. These facilities offer shorter patient wait times, reduced healthcare costs, faster recovery, and improved operational efficiency compared with traditional hospitals. Additionally, favorable reimbursement trends, increasing patient preference for outpatient care, and rising investments in specialized surgical infrastructure are further driving ASC adoption, supporting strong demand for surgical devices in this setting. “Asia Pacific is expected to grow at the highest CAGR in the surgical devices market during the forecast period.” The surgical devices market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is expected to experience the highest CAGR due to the region’s large patient population, rapidly aging demographics, rising chronic disease burden, and expanding healthcare infrastructure. According to the Journal of the American Medical Directors Association (JAMDA), the prevalence of chronic diseases in China reached 81.1% in 2023, increasing demand for surgical interventions across cardiovascular, oncological, orthopedic, and neurological specialties. Additionally, Japan has one of the world's oldest populations, with more than 10% of its population aged 80 years or older, according to the World Economic Forum. Combined with increasing healthcare expenditure, growing adoption of minimally invasive and robotic-assisted surgeries, and improving access to advanced healthcare services, these factors are accelerating demand for surgical devices across the Asia Pacific region. A breakdown of the primary participants (supply side) for the surgical devices market referred to in this report is provided below: ・ By Company Type: Tier 1 - 35%, Tier 2 - 40%, and Tier 3 - 25% ・ By Designation: C-level Executives - 45%, Directors - 35%, and Others - 20% ・ By Region: North America - 27%, Europe - 25%, Asia Pacific - 30%, Latin America - 8%, and the Middle East & Africa - 10% Prominent players in the surgical devices market include Medtronic (Ireland), Boston Scientific Corporation (US), B Braun SE (Germany), Johnson& Johnson (US), Stryker (US), Intuitive Surgical Operations, Inc. (US), CONMED Corporation (US), Olympus Corporation (Japan) Integra LifeSciences Corporation (US), Teleflex Incorporated (US), and among others. Research Coverage The report analyzes the surgical devices market and estimates its size and future growth potential across segments by product, type, procedure, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will help market leaders/new entrants in this market by providing information on the closest approximations of revenue for the overall ostomy dressing market. This report will help stakeholders understand the competitive landscape and gain deeper insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key drivers, restraints, challenges, and opportunities. This report provides insights into the following pointers: ・ Analysis of key drivers (Rising burden of chronic diseases is accelerating long-term demand for surgical devices, the ageing population is increasing surgical intensity and procedure frequency, minimally invasive and robotic surgery are expanding recurring device demand for surgical device), restraints (High capital intensity and long replacement cycles are restraining the adoption of the advanced surgical platforms, shortage of skilled surgeons and technical expertise), opportunities (Growing transition toward minimally invasive and outpatient surgery is expanding demand for disposable surgical devices), and challenges (Product recalls and device-related safety concerns) ・ Market Penetration: Extensive information on products offered by the major players in the global surgical devices market ・ Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global surgical devices market ・ Market Development: Thorough knowledge and analysis of the profitable rising markets by products, type, procedures, end users, and regions ・ Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global surgical devices market ・ Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global surgical devices market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.3 STUDY SCOPE 32
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION 32
1.3.2 INCLUSIONS & EXCLUSIONS 33
1.3.3 YEARS CONSIDERED 34
1.3.4 CURRENCY CONSIDERED 34
1.4 STAKEHOLDERS 35
2 EXECUTIVE SUMMARY 36
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 36
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 37
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 38
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 39
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 40
3 PREMIUM INSIGHTS 41
3.1 SURGICAL DEVICES MARKET OVERVIEW 41
3.2 NORTH AMERICA: SURGICAL DEVICES MARKET, BY END USER 42
3.3 SURGICAL DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 43
3.4 SURGICAL DEVICES MARKET: REGIONAL MIX 43
3.5 SURGICAL DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES 44
4 MARKET OVERVIEW 45
4.1 INTRODUCTION 45
4.2 MARKET DYNAMICS 45
4.2.1 DRIVERS 46
4.2.1.1 Rising burden of chronic diseases 46
4.2.1.2 Rapidly aging population 46
4.2.1.3 Minimally invasive and robotic surgery 47
4.2.2 RESTRAINTS 47
4.2.2.1 High capital intensity and long replacement cycles 47
4.2.2.2 Shortage of skilled surgeons and technical expertise 47
4.2.3 OPPORTUNITIES 48
4.2.3.1 Growing transition toward minimally invasive and outpatient surgery 48
4.2.4 CHALLENGES 48
4.2.4.1 Product recalls and device-related safety events 48
 
4.3 UNMET NEEDS & WHITE SPACES 55
4.3.1 UNMET NEEDS IN SURGICAL DEVICES MARKET 55
4.3.2 WHITE SPACE OPPORTUNITIES 56
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 56
4.4.1 INTERCONNECTED MARKETS 56
4.4.2 CROSS-SECTOR OPPORTUNITIES 56
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 57
5 INDUSTRY TRENDS 58
5.1 PORTER’S FIVE FORCES ANALYSIS 58
5.1.1 THREAT OF NEW ENTRANTS 59
5.1.2 THREAT OF SUBSTITUTES 59
5.1.3 BARGAINING POWER OF BUYERS 60
5.1.4 BARGAINING POWER OF SUPPLIERS 60
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 60
5.2 MACROECONOMIC OUTLOOK 60
5.2.1 INTRODUCTION 60
5.2.2 GDP TRENDS & FORECAST 61
5.2.3 TRENDS IN MINIMALLY INVASIVE SURGERY (MIS) INDUSTRY 62
5.2.4 TRENDS IN SURGICAL ROBOTS INDUSTRY 63
5.3 SUPPLY CHAIN ANALYSIS 63
5.4 VALUE CHAIN ANALYSIS 64
5.5 ECOSYSTEM ANALYSIS 66
5.6 PRICING ANALYSIS 67
5.6.1 AVERAGE SELLING PRICE TREND OF SURGICAL DEVICES,
BY KEY PLAYER (2023–2025) 67
5.6.2 AVERAGE SELLING PRICE TREND OF SURGICAL DEVICES,
BY REGION (2023–2025) 67
5.7 TRADE ANALYSIS 68
5.7.1 IMPORT SCENARIO (HS CODE 9018) 68
5.7.2 EXPORT DATA (HS CODE 9018) 69
5.8 KEY CONFERENCES & EVENTS, 2026–2027 69
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 70
5.10 INVESTMENT & FUNDING SCENARIO 70
5.11 IMPACT OF 2025 US TARIFFS ON SURGICAL DEVICES MARKET 71
5.11.1 INTRODUCTION 71
5.11.2 KEY TARIFF RATES 72
5.11.3 PRICE IMPACT ANALYSIS 73
5.11.4 IMPACT ON COUNTRIES/REGIONS 73
5.11.4.1 North America 73
5.11.4.2 Europe 73
5.11.4.3 Asia Pacific 73
5.11.5 END-USE INDUSTRY IMPACT 74
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 75
6.1 KEY EMERGING TECHNOLOGIES 75
6.1.1 ROBOTIC-ASSISTED & COMPUTER-ASSISTED SURGICAL SYSTEMS 75
6.1.2 AI-ENABLED SURGICAL SOFTWARE, ANALYTICS, AND SMART DEVICE INTEGRATION 75
6.2 COMPLEMENTARY TECHNOLOGIES 75
6.2.1 DIGITAL SURGICAL WORKFLOW, TRAINING, AND CONNECTED OR ECOSYSTEMS 76
6.3 TECHNOLOGY/PRODUCT ROADMAP 76
6.3.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 76
6.3.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 76
6.3.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 77
6.4 PATENT ANALYSIS 78
6.4.1 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS 79
6.5 FUTURE APPLICATIONS 79
6.5.1 AI-ENABLED ROBOTIC & COMPUTER-ASSISTED SURGERY 79
6.5.2 CONNECTED OPERATING ROOM & DIGITAL SUPPORT ECOSYSTEMS 80
6.6 IMPACT OF AI/GEN AI ON SURGICAL DEVICES MARKET 80
6.6.1 TOP USE CASES & MARKET POTENTIAL 80
6.6.2 CASE STUDIES OF AI IMPLEMENTATION IN SURGICAL DEVICES MARKET 81
6.6.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 81
6.6.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN SURGICAL DEVICES MARKET 82
7 SUSTAINABILITY & REGULATORY LANDSCAPE 83
7.1 REGIONAL REGULATIONS & COMPLIANCE 83
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
7.1.2 INDUSTRY STANDARDS 85
7.2 SUSTAINABILITY INITIATIVES 86
7.2.1 CARBON IMPACT & ECO-APPLICATIONS OF SURGICAL DEVICES MARKET 86
7.2.1.1 Carbon impact reduction 86
7.2.1.2 Eco-applications 86
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 87
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 87
7.5 REIMBURSEMENT ANALYSIS 88
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 89
8.1 DECISION-MAKING PROCESS 89
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 89
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 89
8.2.2 KEY BUYING CRITERIA 90
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 91
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 91
8.5 MARKET PROFITABILITY 91
8.5.1 REVENUE POTENTIAL 92
8.5.2 COST DYNAMICS 92
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 92
9 SURGICAL DEVICES MARKET, BY TYPE 93
9.1 INTRODUCTION 94
9.2 SOFT TISSUE SURGICAL DEVICES 94
9.2.1 HIGH PROCEDURE VOLUMES ACROSS SOFT TISSUE SURGERIES TO DRIVE DOMINANCE 94
9.3 HARD TISSUE SURGICAL DEVICES 95
9.3.1 RISING BURDEN OF MUSCULOSKELETAL DISORDERS AND GROWING ADOPTION OF ADVANCED ORTHOPEDIC TECHNOLOGIES TO SUPPORT DEMAND 95
9.4 HYBRID PLATFORMS 97
9.4.1 GROWING DEMAND FOR VERSATILE SURGICAL TECHNOLOGIES TO SUPPORT SEGMENTAL GROWTH 97
10 SURGICAL DEVICES MARKET, BY PRODUCT 98
10.1 INTRODUCTION 99
10.2 IMPLANTS 99
10.2.1 ORTHOPEDIC & SPORTS MEDICINE IMPLANTS 101
10.2.1.1 High procedure volumes to drive demand for orthopedic & sports medicine implants 101
10.2.2 CARDIOVASCULAR IMPLANTS 102
10.2.2.1 High burden of cardiovascular diseases and growing need for structural heart interventions to support demand 102
10.2.3 SPINAL IMPLANTS 103
10.2.3.1 Rising burden of degenerative spine disorders to support spinal implant demand 103
10.2.4 NEUROSURGICAL IMPLANTS 104
10.2.4.1 Expanding neurological and cerebrovascular disease burden to drive neurosurgical implant demand 104
10.2.5 DENTAL IMPLANTS 105
10.2.5.1 Large oral disease and tooth-loss burden to support market growth 105
10.2.6 SOFT TISSUE & MESH IMPLANTS 106
10.2.6.1 Growing hernia procedure volumes and abdominal wall reconstruction needs to drive mesh implant adoption 106
10.2.7 OPHTHALMIC IMPLANTS 107
10.2.7.1 Growing number of cataract surgeries worldwide to continue to support market growth 107
10.2.8 OTHER SPECIALTY IMPLANTS 109
10.3 CAPITAL EQUIPMENT 110
10.3.1 SURGICAL ROBOTIC SYSTEMS 111
10.3.1.1 Rising minimally invasive procedure volumes and hospital robotic capacity expansion to drive demand 111
10.3.2 IMAGING & SURGICAL NAVIGATION SYSTEMS 112
10.3.2.1 Demand for real-time guidance, accuracy, and lower radiation exposure to support adoption 112
10.3.3 ENERGY GENERATORS & PLATFORMS 113
10.3.3.1 Persistent need for precise cutting, coagulation, and bleeding control to support demand 113
10.3.4 OR INTEGRATION & VISUALIZATION SYSTEMS 115
10.3.4.1 Data visibility, intraoperative image management, and digital workflow control to support demand 115
10.3.5 SURGICAL MICROSCOPES & EXOSCOPES 116
10.3.5.1 High-magnification visualization, surgeon ergonomics, and broader microsurgical use to boost growth 116
10.3.6 INSUFFLATORS & FLUID MANAGEMENT SYSTEMS 117
10.3.6.1 Expanding minimally invasive and endoscopic procedure volumes to propel market growth 117
10.4 SINGLE-USE CONSUMABLES 118
10.4.1 SURGICAL STAPLERS & CLIP APPLIERS 119
10.4.1.1 Growing gastrointestinal, bariatric, and colorectal surgery volumes to fuel growth 119
10.4.2 SUTURES & WOUND CLOSURE PRODUCTS 120
10.4.2.1 Rising surgical procedure volumes and trauma-related wound management needs to fuel market 120
10.4.3 SINGLE-USE ENERGY DEVICES 122
10.4.3.1 Growing minimally invasive and robot-assisted surgery volumes to drive utilization of single-use energy devices 122
10.4.4 TROCARS & ACCESS DEVICES 123
10.4.4.1 Rising minimally invasive surgery volumes across multiple specialties to contribute to market growth 123
10.4.5 HEMOSTATS & SEALANTS 124
10.4.5.1 Growing volumes of cardiovascular, orthopedic, and complex surgical procedures to drive market growth 124
10.5 SURGICAL ENDOSCOPY EQUIPMENT 125
10.5.1 RIGID ENDOSCOPES 127
10.5.1.1 Expanding minimally invasive surgical procedure volumes across multiple specialties to fuel growth 127
10.5.2 FLEXIBLE ENDOSCOPES 128
10.5.2.1 Growing volumes of cardiovascular, orthopedic, and complex surgical procedures to boost demand 128
 
10.6 REUSABLE SURGICAL INSTRUMENTS 129
10.6.1 POWERED INSTRUMENTS 130
10.6.1.1 Increasing complex reconstructive procedure volumes to drive demand 130
10.6.2 HANDHELD INSTRUMENTS 132
10.6.2.1 Broad utilization across general, cardiovascular, oncologic, and specialty surgeries to sustain demand 132
10.7 ACCESSORIES & ANCILLARY PRODUCTS 133
11 SURGICAL DEVICES MARKET, BY PROCEDURE 135
11.1 INTRODUCTION 136
11.2 ORTHOPEDICS 136
11.2.1 RISING BURDEN OF MUSCULOSKELETAL DISORDERS TO DRIVE GROWTH OF ORTHOPEDIC SURGICAL DEVICES SEGMENT 136
11.3 CARDIOVASCULAR 137
11.3.1 RISING CARDIOVASCULAR DISEASE BURDEN TO DRIVE SUSTAINED DEMAND FOR CARDIOVASCULAR SURGICAL DEVICES 137
11.4 GENERAL SURGERY 139
11.4.1 HIGH SURGICAL PROCEDURE VOLUMES ACROSS MULTIPLE SPECIALTIES TO DRIVE DEMAND FOR GENERAL SURGERY DEVICES 139
11.5 GASTROINTESTINAL 140
11.5.1 RISING BURDEN OF GASTROINTESTINAL DISORDERS TO DRIVE DEMAND FOR GASTROINTESTINAL SURGICAL PROCEDURES 140
11.6 NEUROLOGY 141
11.6.1 RISING BURDEN OF NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH 141
11.7 GYNECOLOGY 142
11.7.1 GROWING BURDEN OF GYNECOLOGICAL CANCERS TO DRIVE DEMAND FOR GYNECOLOGICAL SURGICAL PROCEDURES 142
11.8 UROLOGY 143
11.8.1 RISING PREVALENCE OF CHRONIC KIDNEY DISEASE AND UROLOGICAL CANCERS TO BOOST MARKET 143
11.9 DENTAL 144
11.9.1 GROWING DEMAND FOR DENTAL IMPLANTS AND COSMETIC DENTISTRY TO ACCELERATE SEGMENT GROWTH 144
11.10 ENT 145
11.10.1 RISING INCIDENCE OF ENT DISORDERS TO DRIVE GROWTH 145
11.11 PEDIATRICS 146
11.11.1 RISING ULCERATIVE COLITIS PREVALENCE TO DRIVE SEGMENTAL GROWTH 146
11.12 OTHER PROCEDURES 147
12 SURGICAL DEVICES MARKET, BY END USER 148
12.1 INTRODUCTION 149
12.2 HOSPITALS 149
12.2.1 HIGH SURGICAL PROCEDURE VOLUMES AND ADOPTION OF ADVANCED SURGICAL TECHNOLOGIES TO SUPPORT HOSPITAL DOMINANCE 149
12.3 AMBULATORY SURGICAL CENTERS 150
12.3.1 GROWING SHIFT TOWARD COST-EFFECTIVE OUTPATIENT SURGERIES AND MINIMALLY INVASIVE PROCEDURES TO DRIVE SEGMENT GROWTH 150
12.4 SPECIALTY CLINICS 151
12.4.1 RISING DEMAND FOR SPECIALIZED SURGICAL CARE TO SUPPORT SEGMENT GROWTH 151
12.5 OTHER END USERS 152
13 SURGICAL DEVICES MARKET, BY REGION 154
13.1 INTRODUCTION 155
13.2 NORTH AMERICA 156
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 156
13.2.2 US 162
13.2.2.1 US to hold major share in North American surgical devices market 162
13.2.3 CANADA 166
13.2.3.1 Growing chronic disease burden and aging population to support Canada's market growth 166
13.3 EUROPE 170
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 170
13.3.2 GERMANY 175
13.3.2.1 Germany held major share in European surgical devices market 175
13.3.3 UK 178
13.3.3.1 Growing burden of musculoskeletal and cardiovascular diseases to support surgical device demand in UK 178
13.3.4 FRANCE 183
13.3.4.1 Rising burden of cardiovascular disease and cancer to aid market growth 183
13.3.5 ITALY 186
13.3.5.1 Rising cancer burden and growing demand for advanced surgical care support to drive demand 186
13.3.6 SPAIN 191
13.3.6.1 growing aging population and rising burden of chronic diseases to aid market growth 191
13.3.7 REST OF EUROPE 194
13.4 ASIA PACIFIC 199
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 199
13.4.2 CHINA 204
13.4.2.1 China held major share of Asia Pacific surgical devices market 204
13.4.3 JAPAN 208
13.4.3.1 Rising aging population and rising burden of cancer to drive market growth 208
13.4.4 INDIA 212
13.4.4.1 Rising chronic disease burden, aging population, and expanding healthcare access to drive rapid market growth 212
 
13.4.5 AUSTRALIA 217
13.4.5.1 High burden of cardiovascular and musculoskeletal disorders to support surgical device demand 217
13.4.6 SOUTH KOREA 221
13.4.6.1 Aging population and rising cancer burden to support surgical device demand in South Korea 221
13.4.7 REST OF ASIA PACIFIC 225
13.5 LATIN AMERICA 229
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 229
13.5.2 BRAZIL 233
13.5.2.1 Brazil to holds largest share in Latin American market 233
13.5.3 MEXICO 238
13.5.3.1 Rising chronic disease burden and growing medical tourism to support market expansion in Mexico 238
13.5.4 REST OF LATIN AMERICA 241
13.6 MIDDLE EAST & AFRICA 246
13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 246
13.6.2 GCC COUNTRIES 251
13.6.2.1 Rising cancer incidence and strong healthcare infrastructure to aid market growth 251
13.6.3 REST OF MIDDLE EAST & AFRICA 255
14 COMPETITIVE LANDSCAPE 259
14.1 INTRODUCTION 259
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 259
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SURGICAL DEVICES MARKET 259
14.3 REVENUE ANALYSIS, 2021–2025 261
14.4 MARKET SHARE ANALYSIS, 2025 261
14.4.1 GLOBAL SURGICAL ROBOTS MARKET SHARE ANALYSIS, 2025 261
14.4.2 GLOBAL ENERGY GENERATORS MARKET SHARE ANALYSIS, 2025 262
14.4.3 GLOBAL SURGICAL SUTURES MARKET SHARE ANALYSIS, 2025 263
14.4.4 GLOBAL SURGICAL STAPLERS MARKET SHARE ANALYSIS, 2025 263
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 264
14.5.1 STARS 264
14.5.2 EMERGING LEADERS 264
14.5.3 PERVASIVE PLAYERS 265
14.5.4 PARTICIPANTS 265
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 266
14.5.5.1 Company footprint 266
14.5.5.2 Region footprint 267
14.5.5.3 Type footprint 268
 
14.5.5.4 Product footprint 269
14.5.5.5 Procedure footprint 270
14.5.5.6 End-user footprint 271
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 272
14.6.1 PROGRESSIVE COMPANIES 272
14.6.2 RESPONSIVE COMPANIES 272
14.6.3 DYNAMIC COMPANIES 273
14.6.4 STARTING BLOCKS 273
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 274
14.6.5.1 Detailed list of key startups/SMEs 274
14.6.5.2 Competitive benchmarking of key startups/SMEs 275
14.7 COMPANY VALUATION & FINANCIAL METRICS 276
14.7.1 FINANCIAL METRICS 276
14.7.2 COMPANY VALUATION 276
14.8 BRAND/PRODUCT COMPARISON 277
14.9 COMPETITIVE SCENARIO 277
14.9.1 PRODUCT LAUNCHES & APPROVALS 277
14.9.2 DEALS 278
14.9.3 EXPANSIONS 279
15 COMPANY PROFILES 280
15.1 KEY PLAYERS 280
15.1.1 MEDTRONIC PLC 280
15.1.1.1 Business overview 280
15.1.1.2 Products offered 281
15.1.1.3 Recent developments 282
15.1.1.3.1 Product approvals 282
15.1.1.3.2 Other developments 283
15.1.1.4 MnM view 283
15.1.1.4.1 Right to win 283
15.1.1.4.2 Strategic choices 283
15.1.1.4.3 Weaknesses & competitive threats 283
15.1.2 JOHNSON & JOHNSON 284
15.1.2.1 Business overview 284
15.1.2.2 Products offered 285
15.1.2.3 Recent developments 287
15.1.2.3.1 Product launches & approvals 287
15.1.2.3.2 Deals 287
15.1.2.3.3 Expansions 288
 
15.1.2.4 MnM view 288
15.1.2.4.1 Right to win 288
15.1.2.4.2 Strategic choices 289
15.1.2.4.3 Weaknesses & competitive threats 289
15.1.3 STRYKER CORPORATION 290
15.1.3.1 Business overview 290
15.1.3.2 Products offered 291
15.1.3.3 Recent developments 292
15.1.3.3.1 Deals 292
15.1.4 B. BRAUN 293
15.1.4.1 Business overview 293
15.1.4.2 Products offered 294
15.1.4.3 Recent developments 295
15.1.4.3.1 Deals 295
15.1.4.3.2 Expansions 295
15.1.4.4 MnM view 296
15.1.4.4.1 Right to win 296
15.1.4.4.2 Strategic choices 296
15.1.4.4.3 Weaknesses & competitive threats 296
15.1.5 INTUITIVE SURGICAL 297
15.1.5.1 Business overview 297
15.1.5.2 Products offered 298
15.1.5.3 Recent developments 299
15.1.5.3.1 Product approvals 299
15.1.5.3.2 Expansions 299
15.1.6 SIEMENS HEALTHINEERS AG 300
15.1.6.1 Business overview 300
15.1.6.2 Products offered 301
15.1.6.3 Recent developments 302
15.1.6.3.1 Product launches & approvals 302
15.1.6.3.2 Expansions 303
15.1.7 OLYMPUS CORPORATION 304
15.1.7.1 Business overview 304
15.1.7.2 Products offered 305
15.1.7.3 Recent developments 306
15.1.7.3.1 Product launches & approvals 306
15.1.8 ZIMMER BIOMET HOLDINGS, INC. 308
15.1.8.1 Business overview 308
15.1.8.2 Products offered 309
15.1.8.3 Recent developments 311
15.1.8.3.1 Product launches & approvals 311
15.1.8.3.2 Deals 311
15.1.9 BOSTON SCIENTIFIC CORPORATION 312
15.1.9.1 Business overview 312
15.1.9.2 Products offered 313
15.1.9.3 Recent developments 314
15.1.9.3.1 Product launches & approvals 314
15.1.10 CONMED CORPORATION 315
15.1.10.1 Business overview 315
15.1.10.2 Products offered 316
15.1.10.3 Recent developments 317
15.1.10.3.1 Product launches 317
15.1.10.3.2 Expansions 318
15.2 OTHER PLAYERS 319
15.2.1 BAXTER INTERNATIONAL INC. 319
15.2.2 HEALTHIUM MEDTECH LIMITED 320
15.2.3 ABBOTT 321
15.2.4 GLOBUS MEDICAL, INC. 322
15.2.5 BECTON, DICKINSON AND COMPANY 323
15.2.6 SMITH+NEPHEW 324
15.2.7 MICROPORT SCIENTIFIC CORPORATION 325
15.2.8 INTEGRA LIFESCIENCES 326
15.2.9 COOK MEDICAL 327
15.2.10 ARTHREX, INC. 328
15.2.11 ADVANCED MEDICAL SOLUTIONS GROUP PLC 329
15.2.12 ASPEN SURGICAL PRODUCTS, INC. 330
15.2.13 FUJIFILM HOLDINGS CORPORATION 332
15.2.14 KARL STORZ 333
15.2.15 STERIS PLC 334
16 RESEARCH METHODOLOGY 335
16.1 RESEARCH DATA 335
16.1.1 SECONDARY DATA 336
16.1.1.1 Key data from secondary sources 337
16.1.2 PRIMARY DATA 338
16.1.2.1 Key data from primary sources 339
16.1.2.2 Key industry insights 340
16.2 MARKET SIZE ESTIMATION 341
16.3 MARKET BREAKDOWN & DATA TRIANGULATION 346
16.4 MARKET RANKING ANALYSIS 347
16.5 STUDY ASSUMPTIONS 347
 
16.6 RESEARCH LIMITATIONS 347
16.6.1 METHODOLOGY-RELATED LIMITATIONS 347
16.6.2 SCOPE-RELATED LIMITATIONS 347
16.7 RISK ASSESSMENT 348
17 APPENDIX 349
17.1 DISCUSSION GUIDE 349
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 356
17.3 CUSTOMIZATION OPTIONS 358
17.4 RELATED REPORTS 358
17.5 AUTHOR DETAILS 359

ページTOPに戻る

List of Tables/Graphs

TABLE 1 SURGICAL DEVICES MARKET: INCLUSIONS & EXCLUSIONS 33
TABLE 2 STANDARD CURRENCY CONVERSION RATES 35
TABLE 3 LIST OF ENDOSCOPES RECALLED BY KEY PLAYERS IN MARKET 49
TABLE 4 SURGICAL DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 58
TABLE 5 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030 61
TABLE 6 AVERAGE SELLING PRICE TREND OF SURGICAL ROBOTS,
BY KEY PLAYER (USD MILLION) 67
TABLE 7 AVERAGE PRICING TREND OF SURGICAL DEVICES, BY REGION, 2023–2025 (USD) 67
TABLE 8 IMPORT DATA FOR SURGICAL DEVICES UNDER HS CODE 9018, BY COUNTRY, 2020–2025 (USD THOUSAND) 68
TABLE 9 EXPORT DATA FOR SURGICAL DEVICES UNDER HS CODE 9018, BY COUNTRY, 2020–2025 (USD THOUSAND) 69
TABLE 10 SURGICAL DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS (2026–2027) 69
TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES 72
TABLE 12 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR SURGICAL DEVICES 73
TABLE 13 TOP USE CASES & MARKET POTENTIAL 80
TABLE 14 SURGICAL DEVICES MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 81
TABLE 15 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 81
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 20 MIDDLE EAST & AFRICA AND GCC COUNTRIES: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 21 GLOBAL STANDARDS IN SURGICAL DEVICES MARKET 85
TABLE 22 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN SURGICAL DEVICES MARKET 87
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR SURGICAL DEVICES 90
TABLE 24 KEY BUYING CRITERIA FOR TOP THREE SURGICAL DEVICES 90
TABLE 25 SURGICAL DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS 91
TABLE 26 SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 94
TABLE 27 SOFT TISSUE SURGICAL DEVICES MARKET, BY COUNTRY,
2024–2031 (USD BILLION) 95
TABLE 28 HARD TISSUE SURGICAL DEVICES MARKET, BY COUNTRY,
2024–2031 (USD BILLION) 96
TABLE 29 HYBRID PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 97
TABLE 30 SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 99
TABLE 31 SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE, 2024–2031 (USD BILLION) 100
TABLE 32 SURGICAL DEVICES MARKET FOR IMPLANTS, BY COUNTRY,
2024–2031 (USD BILLION) 100
TABLE 33 SURGICAL DEVICES MARKET FOR ORTHOPEDIC & SPORTS MEDICINE
IMPLANTS, BY COUNTRY, 2024–2031 (USD BILLION) 101
TABLE 34 SURGICAL DEVICES MARKET FOR CARDIOVASCULAR IMPLANTS,
BY COUNTRY, 2024–2031 (USD BILLION) 102
TABLE 35 SURGICAL DEVICES MARKET FOR SPINAL IMPLANTS, BY COUNTRY,
2024–2031 (USD BILLION) 103
TABLE 36 SURGICAL DEVICES MARKET FOR NEUROSURGICAL IMPLANTS,
BY COUNTRY, 2024–2031 (USD BILLION) 104
TABLE 37 SURGICAL DEVICES MARKET FOR DENTAL IMPLANTS, BY COUNTRY,
2024–2031 (USD BILLION) 105
TABLE 38 SURGICAL DEVICES MARKET FOR SOFT TISSUE & MESH IMPLANTS,
BY COUNTRY, 2024–2031 (USD BILLION) 107
TABLE 39 SURGICAL DEVICES MARKET FOR OPHTHALMIC IMPLANTS, BY COUNTRY,
2024–2031 (USD BILLION) 108
TABLE 40 SURGICAL DEVICES MARKET FOR OTHER SPECIALTY IMPLANTS, BY COUNTRY, 2024–2031 (USD BILLION) 109
TABLE 41 SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 110
TABLE 42 SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY COUNTRY,
2024–2031 (USD BILLION) 111
TABLE 43 SURGICAL DEVICES MARKET FOR SURGICAL ROBOTIC SYSTEMS, BY COUNTRY, 2024–2031 (USD BILLION) 112
TABLE 44 SURGICAL DEVICES MARKET FOR IMAGING & SURGICAL NAVIGATION SYSTEMS,
BY COUNTRY, 2024–2031 (USD BILLION) 113
TABLE 45 SURGICAL DEVICES MARKET FOR ENERGY GENERATORS & PLATFORMS,
BY COUNTRY, 2024–2031 (USD BILLION) 114
TABLE 46 SURGICAL DEVICES MARKET FOR OR INTEGRATION & VISUALIZATION SYSTEMS,
BY COUNTRY, 2024–2031 (USD BILLION) 115
TABLE 47 SURGICAL DEVICES MARKET FOR SURGICAL MICROSCOPES & EXOSCOPES,
BY COUNTRY, 2024–2031 (USD BILLION) 116
TABLE 48 SURGICAL DEVICES MARKET FOR INSUFFLATORS & FLUID MANAGEMENT SYSTEMS, BY COUNTRY, 2024–2031 (USD BILLION) 117
TABLE 49 SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES, BY TYPE,
2024–2031 (USD BILLION) 118
TABLE 50 SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES, BY COUNTRY, 2024–2031 (USD BILLION) 119
TABLE 51 SURGICAL DEVICES MARKET FOR SURGICAL STAPLERS & CLIP APPLIERS,
BY COUNTRY, 2024–2031 (USD BILLION) 120
TABLE 52 SURGICAL DEVICES MARKET FOR SUTURES & WOUND CLOSURE PRODUCTS,
BY COUNTRY, 2024–2031 (USD BILLION) 121
TABLE 53 SURGICAL DEVICES MARKET FOR SINGLE-USE ENERGY DEVICES, BY COUNTRY, 2024–2031 (USD BILLION) 122
TABLE 54 SURGICAL DEVICES MARKET FOR TROCARS & ACCESS DEVICES, BY COUNTRY, 2024–2031 (USD BILLION) 123
TABLE 55 SURGICAL DEVICES MARKET FOR HEMOSTATS & SEALANTS, BY COUNTRY,
2024–2031 (USD BILLION) 124
TABLE 56 SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 126
TABLE 57 SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT,
BY COUNTRY, 2024–2031 (USD BILLION) 126
TABLE 58 SURGICAL DEVICES MARKET FOR RIGID ENDOSCOPES, BY COUNTRY,
2024–2031 (USD BILLION) 127
TABLE 59 SURGICAL DEVICES MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY,
2024–2031 (USD BILLION) 128
TABLE 60 SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS,
BY TYPE, 2024–2031 (USD BILLION) 129
TABLE 61 SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS,
BY COUNTRY, 2024–2031 (USD BILLION) 130
TABLE 62 SURGICAL DEVICES MARKET FOR POWERED INSTRUMENTS, BY COUNTRY,
2024–2031 (USD BILLION) 131
TABLE 63 SURGICAL DEVICES MARKET FOR HANDHELD INSTRUMENTS, BY COUNTRY, 2024–2031 (USD BILLION) 132
TABLE 64 SURGICAL DEVICES MARKET FOR ACCESSORIES & ANCILLARY PRODUCTS,
BY COUNTRY, 2024–2031 (USD BILLION) 133
TABLE 65 SURGICAL DEVICES MARKET, BY PROCEDURE, 2024–2031 (USD BILLION) 136
TABLE 66 SURGICAL DEVICES MARKET FOR ORTHOPEDIC PROCEDURES, BY COUNTRY, 2024–2031 (USD BILLION) 137
TABLE 67 SURGICAL DEVICES MARKET FOR CARDIOVASCULAR PROCEDURES, BY COUNTRY, 2024–2031 (USD BILLION) 138
TABLE 68 SURGICAL DEVICES MARKET FOR GENERAL SURGERY PROCEDURES, BY COUNTRY, 2024–2031 (USD BILLION) 139
TABLE 69 SURGICAL DEVICES MARKET FOR GASTROINTESTINAL PROCEDURES, BY COUNTRY, 2024–2031 (USD BILLION) 140
TABLE 70 SURGICAL DEVICES MARKET FOR NEUROLOGY PROCEDURES, BY COUNTRY, 2024–2031 (USD BILLION) 141
TABLE 71 SURGICAL DEVICES MARKET FOR GYNECOLOGY PROCEDURES, BY COUNTRY, 2024–2031 (USD BILLION) 142
TABLE 72 SURGICAL DEVICES MARKET FOR UROLOGY PROCEDURES, BY COUNTRY,
2024–2031 (USD BILLION) 143
TABLE 73 SURGICAL DEVICES MARKET FOR DENTAL PROCEDURES, BY COUNTRY,
2024–2031 (USD BILLION) 144
TABLE 74 SURGICAL DEVICES MARKET FOR ENT PROCEDURES, BY COUNTRY,
2024–2031 (USD BILLION) 145
TABLE 75 SURGICAL DEVICES MARKET FOR PEDIATRIC PROCEDURES, BY COUNTRY,
2024–2031 (USD BILLION) 146
TABLE 76 SURGICAL DEVICES MARKET FOR OTHER PROCEDURES, BY COUNTRY,
2024–2031 (USD BILLION) 147
TABLE 77 SURGICAL DEVICES MARKET, BY END USER, 2024–2031 (USD BILLION) 149
TABLE 78 SURGICAL DEVICES MARKET FOR HOSPITALS, BY COUNTRY,
2024–2031 (USD BILLION) 150
TABLE 79 SURGICAL DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS,
BY COUNTRY, 2024–2031 (USD BILLION) 151
TABLE 80 SURGICAL DEVICES MARKET FOR SPECIALTY CLINICS, BY COUNTRY,
2024–2031 (USD BILLION) 152
TABLE 81 SURGICAL DEVICES MARKET FOR OTHER END USERS, BY COUNTRY,
2024–2031 (USD BILLION) 153
TABLE 82 SURGICAL DEVICES MARKET, BY REGION, 2024–2031 (USD BILLION) 155
TABLE 83 NORTH AMERICA: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (UNIT) 157
TABLE 84 NORTH AMERICA: SURGICAL DEVICES MARKET, BY COUNTRY,
2024–2031 (USD BILLION) 157
TABLE 85 NORTH AMERICA: SURGICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 157
TABLE 86 NORTH AMERICA: SURGICAL DEVICES MARKET, BY PRODUCT,
2024–2031 (USD BILLION) 158
TABLE 87 NORTH AMERICA: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 158
TABLE 88 NORTH AMERICA: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 159
TABLE 89 NORTH AMERICA: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES, BY TYPE, 2024–2031 (USD BILLION) 159
TABLE 90 NORTH AMERICA: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 160
TABLE 91 NORTH AMERICA: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 160
TABLE 92 NORTH AMERICA: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 161
TABLE 93 NORTH AMERICA: SURGICAL DEVICES MARKET, BY END USER,
2024–2031 (USD BILLION) 161
TABLE 94 US: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 162
TABLE 95 US: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 162
TABLE 96 US: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 163
TABLE 97 US: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE,
2024–2031 (USD BILLION) 163
TABLE 98 US: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 164
TABLE 99 US: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 164
TABLE 100 US: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS,
BY TYPE, 2024–2031 (USD BILLION) 164
TABLE 101 US: SURGICAL DEVICES MARKET, BY PROCEDURE, 2024–2031 (USD BILLION) 165
TABLE 102 US: SURGICAL DEVICES MARKET, BY END USER, 2024–2031 (USD BILLION) 165
TABLE 103 CANADA: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 166
TABLE 104 CANADA: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 166
TABLE 105 CANADA: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 167
TABLE 106 CANADA: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE,
2024–2031 (USD BILLION) 167
TABLE 107 CANADA: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 168
TABLE 108 CANADA: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 168
TABLE 109 CANADA: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 168
TABLE 110 CANADA: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 169
TABLE 111 CANADA: SURGICAL DEVICES MARKET, BY END USER, 2024–2031 (USD BILLION) 169
TABLE 112 EUROPE: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (UNIT) 170
TABLE 113 EUROPE: SURGICAL DEVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 170
TABLE 114 EUROPE: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 171
TABLE 115 EUROPE: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 171
TABLE 116 EUROPE: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 172
TABLE 117 EUROPE: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE,
2024–2031 (USD BILLION) 172
TABLE 118 EUROPE: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 173
TABLE 119 EUROPE: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 173
TABLE 120 EUROPE: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 173
TABLE 121 EUROPE: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 174
TABLE 122 EUROPE: SURGICAL DEVICES MARKET, BY END USER, 2024–2031 (USD BILLION) 174
TABLE 123 GERMANY: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 175
TABLE 124 GERMANY: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 175
TABLE 125 GERMANY: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 176
TABLE 126 GERMANY: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 176
TABLE 127 GERMANY: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 177
TABLE 128 GERMANY: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 177
TABLE 129 GERMANY: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 177
TABLE 130 GERMANY: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 178
TABLE 131 GERMANY: SURGICAL DEVICES MARKET, BY END USER,
2024–2031 (USD BILLION) 178
TABLE 132 UK: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 179
TABLE 133 UK: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 179
TABLE 134 UK: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 180
TABLE 135 UK: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE,
2024–2031 (USD BILLION) 180
TABLE 136 UK: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES, BY TYPE, 2024–2031 (USD BILLION) 181
TABLE 137 UK: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 181
TABLE 138 UK: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS,
BY TYPE, 2024–2031 (USD BILLION) 181
TABLE 139 UK: SURGICAL DEVICES MARKET, BY PROCEDURE, 2024–2031 (USD BILLION) 182
TABLE 140 UK: SURGICAL DEVICES MARKET, BY END USER, 2024–2031 (USD BILLION) 182
TABLE 141 FRANCE: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 183
TABLE 142 FRANCE: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 183
TABLE 143 FRANCE: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 184
TABLE 144 FRANCE: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE,
2024–2031 (USD BILLION) 184
TABLE 145 FRANCE: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 185
TABLE 146 FRANCE: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 185
TABLE 147 FRANCE: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 185
TABLE 148 FRANCE: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 186
TABLE 149 FRANCE: SURGICAL DEVICES MARKET, BY END USER, 2024–2031 (USD BILLION) 186
TABLE 150 ITALY: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 187
TABLE 151 ITALY: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 187
TABLE 152 ITALY: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 188
TABLE 153 ITALY: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE,
2024–2031 (USD BILLION) 188
TABLE 154 ITALY: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 189
TABLE 155 ITALY: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 189
TABLE 156 ITALY: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS,
BY TYPE, 2024–2031 (USD BILLION) 189
TABLE 157 ITALY: SURGICAL DEVICES MARKET, BY PROCEDURE, 2024–2031 (USD BILLION) 190
TABLE 158 ITALY: SURGICAL DEVICES MARKET, BY END USER, 2024–2031 (USD BILLION) 190
TABLE 159 SPAIN: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 191
TABLE 160 SPAIN: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 191
TABLE 161 SPAIN: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 192
TABLE 162 SPAIN: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE,
2024–2031 (USD BILLION) 192
TABLE 163 SPAIN: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 193
TABLE 164 SPAIN: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 193
TABLE 165 SPAIN: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS,
BY TYPE, 2024–2031 (USD BILLION) 193
TABLE 166 SPAIN: SURGICAL DEVICES MARKET, BY PROCEDURE, 2024–2031 (USD BILLION) 194
TABLE 167 SPAIN: SURGICAL DEVICES MARKET, BY END USER, 2024–2031 (USD BILLION) 194
TABLE 168 REST OF EUROPE: SURGICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 195
TABLE 169 REST OF EUROPE: SURGICAL DEVICES MARKET, BY PRODUCT,
2024–2031 (USD BILLION) 195
TABLE 170 REST OF EUROPE: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 196
TABLE 171 REST OF EUROPE: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 196
TABLE 172 REST OF EUROPE: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES, BY TYPE, 2024–2031 (USD BILLION) 197
TABLE 173 REST OF EUROPE: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 197
TABLE 174 REST OF EUROPE: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 197
TABLE 175 REST OF EUROPE: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 198
TABLE 176 REST OF EUROPE: SURGICAL DEVICES MARKET, BY END USER,
2024–2031 (USD BILLION) 198
TABLE 177 ASIA PACIFIC: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (UNIT) 200
TABLE 178 ASIA PACIFIC: SURGICAL DEVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 200
TABLE 179 ASIA PACIFIC: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 200
TABLE 180 ASIA PACIFIC: SURGICAL DEVICES MARKET, BY PRODUCT,
2024–2031 (USD BILLION) 201
TABLE 181 ASIA PACIFIC: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 201
TABLE 182 ASIA PACIFIC: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 202
TABLE 183 ASIA PACIFIC: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 202
TABLE 184 ASIA PACIFIC: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 203
TABLE 185 ASIA PACIFIC: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 203
TABLE 186 ASIA PACIFIC: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 203
TABLE 187 ASIA PACIFIC: SURGICAL DEVICES MARKET, BY END USER,
2024–2031 (USD BILLION) 204
TABLE 188 CHINA: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 204
TABLE 189 CHINA: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 205
TABLE 190 CHINA: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 205
TABLE 191 CHINA: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE,
2024–2031 (USD BILLION) 206
TABLE 192 CHINA: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 206
TABLE 193 CHINA: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 207
TABLE 194 CHINA: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS,
BY TYPE, 2024–2031 (USD BILLION) 207
TABLE 195 CHINA: SURGICAL DEVICES MARKET, BY PROCEDURE, 2024–2031 (USD BILLION) 207
TABLE 196 CHINA: SURGICAL DEVICES MARKET, BY END USER, 2024–2031 (USD BILLION) 208
TABLE 197 JAPAN: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 208
TABLE 198 JAPAN: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 209
TABLE 199 JAPAN: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 209
TABLE 200 JAPAN: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE,
2024–2031 (USD BILLION) 210
TABLE 201 JAPAN: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 210
TABLE 202 JAPAN: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 210
TABLE 203 JAPAN: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS,
BY TYPE, 2024–2031 (USD BILLION) 211
TABLE 204 JAPAN: SURGICAL DEVICES MARKET, BY PROCEDURE, 2024–2031 (USD BILLION) 211
TABLE 205 JAPAN: SURGICAL DEVICES MARKET, BY END USER, 2024–2031 (USD BILLION) 212
TABLE 206 INDIA: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 212
TABLE 207 INDIA: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 213
TABLE 208 INDIA: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 213
TABLE 209 INDIA: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 214
TABLE 210 INDIA: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 214
TABLE 211 INDIA: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 215
TABLE 212 INDIA: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS,
BY TYPE, 2024–2031 (USD BILLION) 215
TABLE 213 INDIA: SURGICAL DEVICES MARKET, BY PROCEDURE, 2024–2031 (USD BILLION) 216
TABLE 214 INDIA: SURGICAL DEVICES MARKET, BY END USER, 2024–2031 (USD BILLION) 216
TABLE 215 AUSTRALIA: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 217
TABLE 216 AUSTRALIA: SURGICAL DEVICES MARKET, BY PRODUCT,
2024–2031 (USD BILLION) 217
TABLE 217 AUSTRALIA: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 218
TABLE 218 AUSTRALIA: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 218
TABLE 219 AUSTRALIA: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 219
TABLE 220 AUSTRALIA: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 219
TABLE 221 AUSTRALIA: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 219
TABLE 222 AUSTRALIA: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 220
TABLE 223 AUSTRALIA: SURGICAL DEVICES MARKET, BY END USER,
2024–2031 (USD BILLION) 220
TABLE 224 SOUTH KOREA: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 221
TABLE 225 SOUTH KOREA: SURGICAL DEVICES MARKET, BY PRODUCT,
2024–2031 (USD BILLION) 221
TABLE 226 SOUTH KOREA: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 222
TABLE 227 SOUTH KOREA: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 222
TABLE 228 SOUTH KOREA: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 223
TABLE 229 SOUTH KOREA: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 223
TABLE 230 SOUTH KOREA: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 223
TABLE 231 SOUTH KOREA: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 224
TABLE 232 SOUTH KOREA: SURGICAL DEVICES MARKET, BY END USER,
2024–2031 (USD BILLION) 224
TABLE 233 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 225
TABLE 234 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET, BY PRODUCT,
2024–2031 (USD BILLION) 225
TABLE 235 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET FOR IMPLANTS,
BY TYPE, 2024–2031 (USD BILLION) 226
TABLE 236 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 226
TABLE 237 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES, BY TYPE, 2024–2031 (USD BILLION) 227
TABLE 238 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 227
TABLE 239 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 227
TABLE 240 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 228
TABLE 241 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET, BY END USER,
2024–2031 (USD BILLION) 228
TABLE 242 LATIN AMERICA: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (UNIT) 229
TABLE 243 LATIN AMERICA: SURGICAL DEVICES MARKET, BY COUNTRY,
2024–2031 (USD BILLION) 229
TABLE 244 LATIN AMERICA: SURGICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 230
TABLE 245 LATIN AMERICA: SURGICAL DEVICES MARKET, BY PRODUCT,
2024–2031 (USD BILLION) 230
TABLE 246 LATIN AMERICA: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 231
TABLE 247 LATIN AMERICA: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 231
TABLE 248 LATIN AMERICA: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 232
TABLE 249 LATIN AMERICA: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 232
TABLE 250 LATIN AMERICA: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 232
TABLE 251 LATIN AMERICA: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 233
TABLE 252 LATIN AMERICA: SURGICAL DEVICES MARKET, BY END USER,
2024–2031 (USD BILLION) 233
TABLE 253 BRAZIL: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 234
TABLE 254 BRAZIL: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 234
TABLE 255 BRAZIL: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 235
TABLE 256 BRAZIL: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE,
2024–2031 (USD BILLION) 235
TABLE 257 BRAZIL: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES,
BY TYPE, 2024–2031 (USD BILLION) 236
TABLE 258 BRAZIL: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 236
TABLE 259 BRAZIL: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS,
BY TYPE, 2024–2031 (USD BILLION) 236
TABLE 260 BRAZIL: SURGICAL DEVICES MARKET, BY PROCEDURE, 2024–2031 (USD BILLION) 237
TABLE 261 BRAZIL: SURGICAL DEVICES MARKET, BY END USER, 2024–2031 (USD BILLION) 237
TABLE 262 MEXICO: SURGICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 238
TABLE 263 MEXICO: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 238
TABLE 264 MEXICO: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 239
TABLE 265 MEXICO: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 239
TABLE 266 MEXICO: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES, BY TYPE, 2024–2031 (USD BILLION) 240
TABLE 267 MEXICO: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 240
TABLE 268 MEXICO: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 240
TABLE 269 MEXICO: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 241
TABLE 270 MEXICO: SURGICAL DEVICES MARKET, BY END USER, 2024–2031 (USD BILLION) 241
TABLE 271 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 242
TABLE 272 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET, BY PRODUCT,
2024–2031 (USD BILLION) 242
TABLE 273 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE, 2024–2031 (USD BILLION) 243
TABLE 274 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 243
TABLE 275 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES, BY TYPE, 2024–2031 (USD BILLION) 244
TABLE 276 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 244
TABLE 277 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 244
TABLE 278 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 245
TABLE 279 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET, BY END USER,
2024–2031 (USD BILLION) 245
TABLE 280 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY PRODUCT,
2024–2031 (UNIT) 246
TABLE 281 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY REGION,
2024–2031 (USD BILLION) 246
TABLE 282 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 247
TABLE 283 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY PRODUCT,
2024–2031 (USD BILLION) 247
TABLE 284 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET FOR IMPLANTS,
BY TYPE, 2024–2031 (USD BILLION) 248
TABLE 285 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 248
TABLE 286 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES, BY TYPE, 2024–2031 (USD BILLION) 249
TABLE 287 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 249
TABLE 288 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 249
TABLE 289 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 250
TABLE 290 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY END USER,
2024–2031 (USD BILLION) 250
TABLE 291 GCC COUNTRIES: SURGICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 251
TABLE 292 GCC COUNTRIES: SURGICAL DEVICES MARKET, BY PRODUCT,
2024–2031 (USD BILLION) 251
TABLE 293 GCC COUNTRIES: SURGICAL DEVICES MARKET FOR IMPLANTS, BY TYPE,
2024–2031 (USD BILLION) 252
TABLE 294 GCC COUNTRIES: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT,
BY TYPE, 2024–2031 (USD BILLION) 252
TABLE 295 GCC COUNTRIES: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES, BY TYPE, 2024–2031 (USD BILLION) 253
TABLE 296 GCC COUNTRIES: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 253
TABLE 297 GCC COUNTRIES: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 253
TABLE 298 GCC COUNTRIES: SURGICAL DEVICES MARKET, BY PROCEDURE,
2024–2031 (USD BILLION) 254
TABLE 299 GCC COUNTRIES: SURGICAL DEVICES MARKET, BY END USER,
2024–2031 (USD BILLION) 254
TABLE 300 REST OF MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 255
TABLE 301 REST OF MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY PRODUCT, 2024–2031 (USD BILLION) 255
TABLE 302 REST OF MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET FOR IMPLANTS,
BY TYPE, 2024–2031 (USD BILLION) 256
TABLE 303 REST OF MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET FOR CAPITAL EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 256
TABLE 304 REST OF MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET FOR SINGLE-USE CONSUMABLES, BY TYPE, 2024–2031 (USD BILLION) 257
TABLE 305 REST OF MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET FOR SURGICAL ENDOSCOPY EQUIPMENT, BY TYPE, 2024–2031 (USD BILLION) 257
TABLE 306 REST OF MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET FOR REUSABLE SURGICAL INSTRUMENTS, BY TYPE, 2024–2031 (USD BILLION) 257
TABLE 307 REST OF MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY PROCEDURE, 2024–2031 (USD BILLION) 258
TABLE 308 REST OF MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY END USER, 2024–2031 (USD BILLION) 258
TABLE 309 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN SURGICAL DEVICES MARKET 259
TABLE 310 SURGICAL DEVICES MARKET: REGION FOOTPRINT 267
TABLE 311 SURGICAL DEVICES MARKET: TYPE FOOTPRINT 268
TABLE 312 SURGICAL DEVICES MARKET: PRODUCT FOOTPRINT 269
TABLE 313 SURGICAL DEVICES MARKET: PROCEDURE FOOTPRINT 270
TABLE 314 SURGICAL DEVICES MARKET: END-USER FOOTPRINT 271
TABLE 315 SURGICAL DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 274
TABLE 316 SURGICAL DEVICES MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/SMES 275
TABLE 317 SURGICAL DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2026 277
TABLE 318 SURGICAL DEVICES MARKET: DEALS, JANUARY 2022–MAY 2026 279
TABLE 319 SURGICAL DEVICES MARKET: EXPANSIONS, JANUARY 2022–MAY 2026 279
TABLE 320 MEDTRONIC PLC: COMPANY OVERVIEW 280
TABLE 321 MEDTRONIC PLC: PRODUCTS OFFERED 281
TABLE 322 MEDTRONIC PLC: PRODUCT APPROVALS, JANUARY 2021–MAY 2026 282
TABLE 323 MEDTRONIC PLC: OTHER DEVELOPMENTS, JANUARY 2021–MAY 2026 283
TABLE 324 JOHNSON & JOHNSON: COMPANY OVERVIEW 284
TABLE 325 JOHNSON & JOHNSON: PRODUCTS OFFERED 285
TABLE 326 JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–MAY 2026 287
TABLE 327 JOHNSON & JOHNSON: DEALS, JANUARY 2021–MAY 2026 287
TABLE 328 JOHNSON & JOHNSON: EXPANSIONS, JANUARY 2021–MAY 2026 288
TABLE 329 STRYKER CORPORATION: COMPANY OVERVIEW 290